Study S002224

Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy on β-cell Function and Glycemic Remission Rate in Newly Diagnosed Type 2 Diabetic Patients

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT01776788
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 156
Start: 2012-08
Primary completion: 2015-02
Lead sponsor: The First Affiliated Hospital of Xiamen University
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:insulin lispro injection, exenatide injection; DRUG:insulin lispro injection
Results posted: FALSE

Registered primary outcomes

the glycemic remission rate in different groups [one year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.